Neuro-Oncology Reviews

Volume 25 Number 3
15 February 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 3, 15 February

Jordan JT, Gerstner ER.
Imaging of Brain Tumors.
Continuum (Minneap Minn). 2023 Feb 1;29(1):171-193
. doi: 10.1212/CON.0000000000001202. PMID: 36795877. Review˰ ˍ

Gerardi RM, Cannella R, Bonosi L, Vernuccio F, Ferini G, Viola A, Zagardo V, Buscemi F, Costanzo R, Porzio M, Giovannini EA, Paolini F, Brunasso L, Giammalva GR, Umana GE, Scarpitta A, Iacopino DG, Maugeri R.
Forecasting Molecular Features in IDH-Wildtype Gliomas: The State of the Art of Radiomics Applied to Neurosurgery.
Cancers (Basel). 2023 Feb 2;15(3):940
. doi: 10.3390/cancers15030940. PMID: 36765898. Review. ˍ

Hosseinalizadeh H, Ebrahimi A, Tavakoli A, Monavari SH.
Glioblastoma as a novel drug repositioning target: Updated state.
Anticancer Agents Med Chem. 2023 Feb 2
. doi: 10.2174/1871520623666230202163112. PMID: 36733195. Review˰ ˍ

Jia JL, Alshamsan B, Ng TL.
Temozolomide Chronotherapy in Glioma: A Systematic Review.
Curr Oncol. 2023 Feb 4;30(2):1893-1902
. doi: 10.3390/curroncol30020147. PMID: 36826108. Review. ˍ

Mirchia K, Mahoney MT, Christie O, Fuller CE, Mirchia K.
A Rare Tumor in a Rare Location: Radiology and Pathology Findings With a Literature Review on Intraventricular Gliosarcoma.
Cureus. 2023 Feb 4;15(2):e34622. doi: 10.7759/cureus.34622. PMID: 36891012. Case report, Review. ˍ

Wong SC, Kamarudin MNA, Naidu R.
Anticancer Mechanism of Flavonoids on High-Grade Adult-Type Diffuse Gliomas.
Nutrients. 2023 Feb 4;15(4):797
. doi: 10.3390/nu15040797. PMID: 36839156. Review. ˍ

Kotch C, Brosius SN, De Raedt T, Fisher MJ.
Updates in the Management of Central and Peripheral Nervous System Tumors among Patients with Neurofibromatosis Type 1 and Neurofibromatosis Type 2.
Pediatr Neurosurg. 2023 Feb 6
. doi: 10.1159/000529507. PMID: 36746138. Review. ˍ

Rechberger JS, Power BT, Power EA, Nesvick CL, Daniels DJ.
H3K27-altered diffuse midline glioma: A paradigm shifting opportunity in direct delivery of targeted therapeutics.
Expert Opin Ther Targets. 2023 Feb 6. doi: 10.1080/14728222.2023.2177531. PMID: 36744399. Review˰ ˍ

Young S, Phaterpekar K, Tsang DS, Boldt G, Bauman GS.
Proton Radiotherapy for Management of Medulloblastoma: A Systematic Review of Clinical Outcomes.
Adv Radiat Oncol. 2023 Feb 7;8(4):101189. doi: 10.1016/j.adro.2023.101189. PMID: 37008255. Review. ˍ

Eibl RH, Schneemann M.
Medulloblastoma: From TP53 Mutations to Molecular Classification and Liquid Biopsy.
Biology (Basel). 2023 Feb 8;12(2):267
. doi: 10.3390/biology12020267. PMID: 36829544. Review. ˍ

Wang Y, Liu R, Zhang Q, Dong M, Wang D, Chen J, Ou Y, Luo H, Yang K, Wang X.
Charged particle therapy for high-grade gliomas in adults: a systematic review.
Radiat Oncol. 2023 Feb 8;18(1):29
. doi: 10.1186/s13014-022-02187-z. PMID: 36755321. Review. ˍ

Crainic N, Furtner J, Pallud J, Bielle F, Lombardi G, Rudà R, Idbaih A.
Rare Neuronal, Glial and Glioneuronal Tumours in Adults.
Cancers (Basel). 2023 Feb 9;15(4):1120
. doi: 10.3390/cancers15041120. PMID: 36831464. Review. ˍ


Kim Y, Armstrong TS, Gilbert MR, Celiku O.
A Critical Analysis of Neuro-Oncology Clinical Trials.
Neuro Oncol. 2023 Feb 9:noad036
. doi: 10.1093/neuonc/noad036. PMID: 36757281. Review. ˍ

Makowska M, Smolarz B, Romanowicz H.
microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)-Recent Literature Review.
Int J Mol Sci. 2023 Feb 9;24(4):3521
. doi: 10.3390/ijms24043521. PMID: 36834933. Review. ˍ


Schramm MWJ, Currie S, Lee MT, Livermore LJ, Solanki SP, Mathew RK, Wurdak H, Lorger M, Twelves C, Short SC, Chakrabarty A, Chumas P.
Do animal models of brain tumors replicate human peritumoral edema? a systematic literature search.
J Neurooncol. 2023 Feb 9
. doi: 10.1007/s11060-023-04246-1. PMID: 36757526. Review. ˍ

Hosseinalizadeh H, Rahmati M, Ebrahimi A, O'Connor RS.
Current Status and Challenges of Vaccination Therapy for Glioblastoma.
Mol Cancer Ther. 2023 Feb 10:MCT-22-0503
. doi: 10.1158/1535-7163.MCT-22-0503. PMID: 36779991. Review˰ ˍ

Nabavizadeh A, Barkovich MJ, Mian A, Ngo V, Kazerooni AF, Villanueva-Meyer JE.
Current state of pediatric neuro-oncology imaging, challenges and future directions.
Neoplasia. 2023 Feb 10;37:100886
. doi: 10.1016/j.neo.2023.100886. PMID: 36774835. Review. ˍ

Shi Y, Liu C, Cheng D, Tang L, Qi Z.
Effects of gross total resection and subtotal resection on survival outcomes of glioma patients: a meta-analysis.
Biotechnol Genet Eng Rev. 2023 Feb 10:1-24
. doi: 10.1080/02648725.2023.2177034. PMID: 36772792. Meta-analysis˰ ˍ

Xie Y, Hou T, Liu J, Zhang H, Liu X, Kang R, Tang D.
Autophagy-dependent ferroptosis as a potential treatment for glioblastoma.
Front Oncol. 2023 Feb 10;13:1091118
. doi: 10.3389/fonc.2023.1091118. PMID: 36845736. Review. ˍ

Young JS, Al-Adli N, Scotford K, Cha S, Berger MS.
Pseudoprogression versus true progression in glioblastoma: what neurosurgeons need to know.
J Neurosurg. 2023 Feb 10:1-12
. doi: 10.3171/2022.12.JNS222173(?). PMID: 36790010. Review˰ ˍ


Decraene B, Vanmechelen M, Clement P, Daisne JF, Vanden Bempt I, Sciot R, Garg AD, Agostinis P, De Smet F, De Vleeschouwer S.
Cellular and molecular features related to exceptional therapy response and extreme long-term survival in glioblastoma.
Cancer Med. 2023 Feb 12
. doi: 10.1002/cam4.5681. PMID: 36776000. Review. ˍ

Aronica E, Ciusani E, Coppola A, Costa C, Russo E, Salmaggi A, Perversi F, Maschio M.
Epilepsy and brain tumors: Two sides of the same coin.
J Neurol Sci. 2023 Feb 13;446:120584
. doi: 10.1016/j.jns.2023.120584. PMID: 36842341. Review. ˍ

Farrukh S, Habib S, Rafaqat A, Sarfraz Z, Sarfraz A, Sarfraz M, Robles-Velasco K, Felix M, Cherrez-Ojeda I.
Emerging Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma: A Systematic Review.
Healthcare (Basel). 2023 Feb 13;11(4):559
. doi: 10.3390/healthcare11040559. PMID: 36833093. Review. ˍ

Armitage AE, Fonkem E.
Supportive care of neurodegenerative patients.
Front Oncol. 2023 Feb 14;13:1029938
. doi: 10.3389/fonc.2023.1029938. PMID: 36865803. Review. ˍ

Durrani S, Tebha SS, Qamar MA, Nathani KR, Harrison DJ, Aljameey UA, Jarrah R, Shoushtari A, Bydon M.
Central neurocytomas: research trends, most cited papers, and scientometrics analysis to date.
Neurosurg Rev. 2023 Feb 14;46(1):57. doi: 10.1007/s10143-023-01960-2. PMID: 36786867. Bibliometric analysis˰ ˍ

Lechpammer M, Mahammedi A, Pomeranz Krummel DA, Sengupta S.
Lessons learned from evolving frameworks in adult glioblastoma.
Handb Clin Neurol. 2023 Feb 14;192:131-140
. doi: 10.1016/B978-0-323-85538-9.00011-0. PMID: 36796938. Review˰ ˍ

Petković M, Henis M, Heese O, Relógio A.
Chronotherapy in Glioblastoma: State of the art and future perspectives.
EBioMedicine. 2023 Feb 14;89:104470
. doi: 10.1016/j.ebiom.2023.104470. PMID: 36796229. Review. ˍ

Singer L, Primdahl D, Kumthekar P.
Neuro-Oncology in Women: Clinical Considerations.
Neurol Clin. 2023 Feb 14;41(2):331-342. doi: 10.1016/j.ncl.2022.10.005. PMID: 37030961. Review˰ ˍ

Fares J, Davis ZB, Rechberger JS, Toll SA, Schwartz JD, Daniels DJ, Miller JS, Khatua S.
Advances in NK cell therapy for brain tumors.
NPJ Precis Oncol. 2023 Feb 15;7(1):17
. doi: 10.1038/s41698-023-00356-1. PMID: 36792722. Review. ˍ

Lassman AB, van den Bent MJ.
What is a glioblastoma?
Neuro Oncol. 2023 Feb 15:noad044
. doi: 10.1093/neuonc/noad044. PMID: 36789896. Editorial. ˍ